×
ADVERTISEMENT

NOVEMBER 21, 2017

FDA Grants New Indication to NSS-2 Bridge to Reduce Opioid Withdrawal Symptoms

The FDA granted a new indication to an electric stimulation device (Bridge Neurostimulation System, NSS-2 Bridge, Innovative Health Solutions) for use in helping to reduce the symptoms of opioid withdrawal.

The NSS-2 Bridge device is a small electrical nerve stimulator placed behind the patient’s ear, that contains a battery-powered chip, which emits electrical pulses to stimulate branches of certain cranial nerves. Such stimulation may provide relief from opioid withdrawal symptoms.